Pro-Dex, Inc. (PDEX)

73.41 +11.66 (+18.88%) USD  |  NASDAQ  |  Sep 04, 16:00
73.26 -0.15 (-0.20%) After-Hours: 20:00
More

Pro-Dex SG&A Expense (TTM) : 5.452M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PDEX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 5.452M
March 31, 2026 6.694M
December 31, 2025 5.693M
September 30, 2025 5.381M
June 30, 2025 5.185M
March 31, 2025 4.845M
December 31, 2024 4.663M
September 30, 2024 4.462M
June 30, 2024 4.188M
March 31, 2024 4.34M
December 31, 2023 4.344M
September 30, 2023 4.126M
June 30, 2023 4.183M
March 31, 2023 4.642M
December 31, 2022 4.774M
September 30, 2022 4.942M
June 30, 2022 4.995M
March 31, 2022 4.811M
December 31, 2021 5.062M
September 30, 2021 4.961M
June 30, 2021 4.666M
March 31, 2021 4.612M
December 31, 2020 4.082M
September 30, 2020 3.795M
June 30, 2020 3.765M
Date Value
March 31, 2020 3.306M
December 31, 2019 3.183M
September 30, 2019 3.114M
June 30, 2019 2.907M
March 31, 2019 2.698M
December 31, 2018 2.719M
September 30, 2018 2.652M
June 30, 2018 2.645M
March 31, 2018 2.819M
December 31, 2017 2.892M
September 30, 2017 2.993M
June 30, 2017 3.115M
March 31, 2017 3.025M
December 31, 2016 2.759M
September 30, 2016 2.67M
June 30, 2016 2.705M
March 31, 2016 2.719M
December 31, 2015 3.083M
September 30, 2015 3.053M
June 30, 2015 2.938M
March 31, 2015 2.819M
December 31, 2014 2.461M
September 30, 2014 2.377M
June 30, 2014 2.293M
March 31, 2014 2.534M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Abbott Laboratories 13.94B
AngioDynamics, Inc. 157.09M
Alphatec Holdings, Inc. 524.06M
AtriCure, Inc. 323.68M
Baxter International, Inc. 2.932B